These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis. Cappellano G; Woldetsadik AD; Orilieri E; Shivakumar Y; Rizzi M; Carniato F; Gigliotti CL; Boggio E; Clemente N; Comi C; Dianzani C; Boldorini R; Chiocchetti A; Renò F; Dianzani U Vaccine; 2014 Sep; 32(43):5681-9. PubMed ID: 25149432 [TBL] [Abstract][Full Text] [Related]
8. Combination of apoptotic T cell induction and self-peptide administration for therapy of experimental autoimmune encephalomyelitis. Kasagi S; Wang D; Zhang P; Zanvit P; Chen H; Zhang D; Li J; Che L; Maruyama T; Nakatsukasa H; Wu R; Jin W; Sun L; Chen W EBioMedicine; 2019 Jun; 44():50-59. PubMed ID: 31097410 [TBL] [Abstract][Full Text] [Related]
9. Regulatory T Cells in Hepatic Immune Tolerance and Autoimmune Liver Diseases. Herkel J Dig Dis; 2015; 33 Suppl 2():70-4. PubMed ID: 26642346 [TBL] [Abstract][Full Text] [Related]
10. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen. Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518 [TBL] [Abstract][Full Text] [Related]
11. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells. Kumar V; Sercarz E J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685 [TBL] [Abstract][Full Text] [Related]
12. Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model. Liu Q; Wang X; Liu X; Kumar S; Gochman G; Ji Y; Liao YP; Chang CH; Situ W; Lu J; Jiang J; Mei KC; Meng H; Xia T; Nel AE ACS Nano; 2019 Apr; 13(4):4778-4794. PubMed ID: 30964276 [TBL] [Abstract][Full Text] [Related]
13. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis. Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934 [TBL] [Abstract][Full Text] [Related]
14. The in vivo and in vitro induction of anterior chamber associated immune deviation to myelin antigens in C57BL/6 mice. Farooq SM; Elkhatib WF; Ashour HM Brain Behav Immun; 2014 Nov; 42():118-22. PubMed ID: 24953428 [TBL] [Abstract][Full Text] [Related]
15. IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis. Wang D; Ghosh D; Islam SM; Moorman CD; Thomason AE; Wilkinson DS; Mannie MD J Immunol; 2016 Oct; 197(8):2992-3007. PubMed ID: 27619998 [TBL] [Abstract][Full Text] [Related]
16. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells. Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928 [TBL] [Abstract][Full Text] [Related]
17. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression. De Paula Pohl A; Schmidt A; Zhang AH; Maldonado T; Königs C; Scott DW Cell Immunol; 2020 Dec; 358():104222. PubMed ID: 33053469 [TBL] [Abstract][Full Text] [Related]